STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer | Life Science Alliance
Identifying biomarkers for chemo-immunotherapy outcomes in PDAC
Tumor-penetrating therapy for β5 integrin-rich pancreas cancer | Nature Communications
Frontiers | Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
Pancreatic Cancer Tumor Markers | GeneTex
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response | Cell Discovery
Role of the tumor microenvironment in pancreatic cancer - Murakami - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library
Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis | PNAS
Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer | Journal of Nuclear Medicine
Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture | BMC Cancer | Full Text
Pancreatic Cancer Tumor Markers | GeneTex
STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer | Life Science Alliance
Immunofluorescence staining of PDTX-PDAC tumor sections. Representative... | Download Scientific Diagram
CD200 promotes immunosuppression in the pancreatic tumor microenvironment | Journal for ImmunoTherapy of Cancer
Cancers | Free Full-Text | Targeting Proliferating Tumor-Infiltrating Macrophages Facilitates Spatial Redistribution of CD8+ T Cells in Pancreatic Cancer
A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling | Science Advances
Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging | eLife
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models | BMC Cancer | Full Text
Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy - eBioMedicine
SPARC dependent collagen deposition and gemcitabine delivery in a genetically engineered mouse model of pancreas cancer - eBioMedicine
Therapeutic targets in the pancreatic adenocarcinoma microenvironment: past challenges and opportunities for the future
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
Stromal mesenchymal stem cells facilitate pancreatic cancer progression by regulating specific secretory molecules through mutual cellular interaction
Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis | PNAS
